NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/09/2025
Voltar para busca
Dado oficial do USPTO
TRANSFILM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
TRANSFILM
ST13
US500000079112545Classe
5, 40, 42
Pedido
79112545
Registro
4315319
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
58
Atualização mais recente
26/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 40, 42
Data de depósito
05/01/2012
Data de registro
09/04/2013
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/06/2024
Última transação
26/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Langenfeld, DE
Examinador
WILLIS,PAMELA Y
Localização atual
Historical data usage
Titulares e representantes
Titulares
Labtec GmbH
Labtec GmbH
Representantes
LEIGH ANN LINDQUIST Sughrue Mion, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations and products for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disordersneurodegenerative disordersinfectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorderscancerallergiesmigraine; sanitary products for medical purposes; pharmaceutical products in form of self-adhesive preparations for medical purposesin particular patches for local application of pharmaceutical substances; carrier substancesdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical productsdrug delivery agents in form of polymer-based transdermal patchestopical patchespatch-like substance carriers to deliver locally active drugs to a local site of actionbuccal patchespatch-like substance carriers to deliver drugs through the buccal mucosa and through the gingival and oral dissolvable films that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
Classe 40
Custom manufacture of pharmaceutical and veterinary products for third partiesin particular of self-adhesive compositions for medical purposesin particular patches for local application of pharmaceutical substances
Classe 42
Researchdevelopment as well as technological consulting in the field of pharmacypharmacologybiotechnology or chemistryall in particular in the field of active substances containing self-adhesive compositions; analysis and evaluation of product development in particular of the self-adhesive active substances containing compositions
Publicações
Histórico de despachos e eventos da marca no USPTO.
58 publicações encontradas
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
28/04/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/02/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
12/06/2024
71AG
REGISTERED-SEC.71 ACCEPTED
12/06/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/05/2024
ES71
TEAS SECTION 71 RECEIVED
02/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/03/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
17/02/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/12/2022
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
07/11/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
14/10/2022
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
15/02/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14/02/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
14/02/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
20/01/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
25/12/2021
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED
06/05/2019
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
06/05/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24/04/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/04/2019
ES75
TEAS SECTION 71 & 15 RECEIVED
05/04/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
28/03/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/04/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
27/07/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/07/2013
FIMP
FINAL DISPOSITION PROCESSED
11/07/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/07/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
09/04/2013
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/04/2013
GPNX
NOTIFICATION PROCESSED BY IB
20/02/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/01/2013
PUBO
PUBLISHED FOR OPPOSITION
22/01/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/01/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/01/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/01/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
17/12/2012
ALIE
ASSIGNED TO LIE
14/12/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/12/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/11/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/11/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/11/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/09/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/09/2012
RFNP
REFUSAL PROCESSED BY IB
25/06/2012
MAFR
APPLICATION FILING RECEIPT MAILED
02/06/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/06/2012
RFRR
REFUSAL PROCESSED BY MPU
01/06/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/06/2012
CNRT
NON-FINAL ACTION WRITTEN
31/05/2012
DOCK
ASSIGNED TO EXAMINER
29/05/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/05/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/05/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TRANSFILM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.